Other Events ·
SS Innovations files updated October 2026 company presentation highlighting $42.5M revenue and surgical robotics growth
SSIISS Innovations International, Inc.
SS Innovations International filed an 8-K to furnish an updated October 2026 investor presentation detailing its commercial progress in the surgical robotics sector. The filing highlights that the company generated approximately $42.5 million in revenue for the full year 2025, with gross margins expanding to 46%. As of September 2026, the SSi Mantra system has been installed at 218 hospitals across 12 countries, facilitating over 14,503 multi-specialty surgeries. The company also reported 195 completed telesurgeries and noted that its US FDA 510(k) review is anticipated to conclude in the first quarter of 2027. SS Innovations International develops advanced, affordable surgical robotic solutions.